Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Moderna to Present at the Chardan Virtual 4th Annual Genetic Medicines Conference


Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Dr. Stephen Hoge, President, will participate in the Chardan Virtual 4th Annual Genetic Medicines Conference on October 5, 2020 at 2:00 p.m. ET.

A live webcast will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com. A replay of the webcast will be archived on Moderna's website for 30 days following the presentation.

About Moderna

Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients. mRNA medicines are designed to direct the body's cells to produce intracellular, membrane or secreted proteins that can have a therapeutic or preventive benefit and have the potential to address a broad spectrum of diseases. Moderna's platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing the Company the capability to pursue in parallel a robust pipeline of new development candidates. Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune and inflammatory diseases, independently and with strategic collaborators.

Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca PLC and Merck & Co., Inc., as well as the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense; the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS) and the Coalition for Epidemic Preparedness Innovations (CEPI). Moderna has been named a top biopharmaceutical employer by Science for the past five years. To learn more, visit www.modernatx.com.


These press releases may also interest you

at 15:23
Boehringer Ingelheim and Atlanta Braves Foundation Partner to Support Shelter Dogs in Need
Boehringer Ingelheim, the largest animal health company in Georgia and its NexGard® PLUS (afoxolaner, moxidectin, and pyrantel chewable tablets) product, and the Atlanta Braves Foundation, the non-profit arm of the Atlanta Braves, are proud to...

at 15:20
Vagus nerve activation of the spleen shows promise to treat infections, Feinstein Institutes research
One of the main roles of the spleen is to help the body's immune system fight infections. The spleen does this through producing and regulating antibodies ? antibody production is negatively affected in various conditions, including sepsis and...

at 15:02
The Inner Circle acknowledges Lee C. Ferguson, DO, FACS as a Pinnacle Lifetime Member
Prominently featured in The Inner Circle, Lee C. Ferguson, DO, FACS is acknowledged as a Pinnacle Lifetime Member for his contributions as a Vascular Surgeon. Dr. Ferguson, a distinguished dual board-certified vascular surgeon and endovascular...

at 15:00
NOTICE TO THE MEDIA - Government of Canada to make an announcement on palliative care
The Honourable David J. McGuinty, Member of Parliament for Ottawa South,  on behalf of the Honourable Mark Holland, Minister of Health, will hold a news conference to announce funding to improve palliative care. MP McGuinty will be available to...

at 14:43
Unveiling a Musical Revolution: Sugar Kayne Radio Set to Launch on 2nd June
Sugar Kayne Radio, an innovative internet radio station founded by Matthew Kayne, also known as DJ Sugar Kayne, is set to launch on 2nd June. Located in the heart of North West London, Sugar Kayne Radio aims to revolutionize the online music...

at 14:38
FDA Roundup: April 26, 2024
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA published the FDA Voices: "A Milestone in Facilitating the Development of Safe and Effective Biosimilars," by Sarah Yim,...

More news about Health...


News published on and distributed by: